Use of toxicokinetic and toxicodynamic data to reduce uncertainties when setting occupational exposure limits for pharmaceuticals
暂无分享,去创建一个
Edward V. Sargent | C. Frank Shen | E. V. Sargent | Bruce D. Naumann | Patricia A. Weideman | Rakesh Dixit | Scott J. Grossman | S. Grossman | P. Weideman | R. Dixit | C. Shen | B. Naumann
[1] A. Renwick. Data-derived safety factors for the evaluation of food additives and environmental contaminants. , 1993, Food additives and contaminants.
[2] J. J. Fleming,et al. Pharmacokinetics and beta‐blocking effects of timolol in poor and extensive metabolizers of debrisoquin , 1985, Clinical pharmacology and therapeutics.
[3] Sandra J. S. Baird,et al. Noncancer Risk Assessment: A Probabilistic Alternative to Current Practice , 1996 .
[4] D Hattis,et al. Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.
[5] Kenny S. Crump,et al. Calculation of Benchmark Doses from Continuous Data , 1995 .
[6] K S Crump,et al. A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[7] Bruce D. Naumann,et al. Scientific basis for uncertainty factors used to establish occupational exposure limits for pharmaceutical active ingredients , 1995 .
[8] E. V. Sargent,et al. Establishing airborne exposure control limits in the pharmaceutical industry. , 1988, American Industrial Hygiene Association journal.
[9] D. Barnes,et al. Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.